Stockscreener 앱 받기
13.55
1.80%
0.24
시간 외 거래:
13.55
전일 마감가:
$13.31
열려 있는:
$14.43
하루 거래량:
1.43M
Relative Volume:
1.23
시가총액:
$961.29M
수익:
$114.04M
순이익/손실:
$-330.15M
주가수익비율:
-2.8647
EPS:
-4.73
순현금흐름:
$-274.85M
1주 성능:
+0.15%
1개월 성능:
+15.12%
6개월 성능:
+215.85%
1년 성능:
-20.99%
1일 변동 폭
$13.11
$14.43
1주일 범위
$13.00
$16.08
52주 변동 폭
$2.21
$19.50
Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile
명칭
Phathom Pharmaceuticals Inc
전화
(877) 742-8466
주소
100 CAMPUS DRIVE,, FLORHAM PARK, NJ
PHAT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PHAT
Phathom Pharmaceuticals Inc
|
13.55 | 944.26M | 114.04M | -330.15M | -274.85M | -4.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-05-03 | 개시 | Stifel | Buy |
| 2024-01-05 | 재확인 | Needham | Buy |
| 2023-08-09 | 개시 | H.C. Wainwright | Buy |
| 2023-05-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-13 | 개시 | Craig Hallum | Buy |
| 2022-10-21 | 개시 | Jefferies | Buy |
| 2022-05-06 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2021-05-12 | 업그레이드 | Goldman | Sell → Neutral |
| 2021-02-17 | 개시 | BMO Capital Markets | Outperform |
| 2021-02-02 | 개시 | Guggenheim | Buy |
| 2020-06-26 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-11-20 | 개시 | Evercore ISI | Outperform |
| 2019-11-19 | 개시 | Goldman | Neutral |
| 2019-11-19 | 개시 | Jefferies | Buy |
| 2019-11-19 | 개시 | Needham | Buy |
모두보기
Phathom Pharmaceuticals Inc 주식(PHAT)의 최신 뉴스
Comparing Phathom Pharmaceuticals Inc. in custom built stock radarsQuarterly Investment Review & Precise Buy Zone Identification - newser.com
Is Phathom Pharmaceuticals Inc. stock a buy on dipsGDP Growth & Reliable Intraday Trade Plans - newser.com
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Just Reported And Analysts Have Been Lifting Their Price Targets - Yahoo Finance
Can Phathom Pharmaceuticals Inc. recover in the next quarterBond Market & Real-Time Stock Price Movement Reports - newser.com
Why Phathom Pharmaceuticals Inc. stock remains a top recommendationWeekly Stock Summary & Short-Term Trading Opportunity Alerts - newser.com
AlphaQuest LLC Buys 30,760 Shares of Phathom Pharmaceuticals, Inc. $PHAT - MarketBeat
Is Phathom Pharmaceuticals Inc. a candidate for recovery playMarket Growth Review & Detailed Earnings Play Strategies - newser.com
Is Phathom Pharmaceuticals Inc. stock positioned for digital transformationJuly 2025 Summary & Real-Time Volume Analysis Alerts - newser.com
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Gap UpTime to Buy? - MarketBeat
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q3 2025 Earnings Call Transcript - Insider Monkey
Will Phathom Pharmaceuticals Inc. stock rally after Fed decisions2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com
Price action breakdown for Phathom Pharmaceuticals Inc.Portfolio Update Summary & AI Based Buy and Sell Signals - newser.com
Phathom Pharmaceuticals’ Q3 Earnings: Strong Growth Amid Challenges - TipRanks
Phathom Pharmaceuticals (PHAT): Forecasts Call for 75% Annual Earnings Growth as Losses Deepen - Yahoo Finance
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Up 8.9% on Strong Earnings - MarketBeat
HC Wainwright & Co. Raises Price Target for PHAT to $26.00 | PHA - GuruFocus
Will Phathom Pharmaceuticals Inc. stock see PE expansionJuly 2025 Summary & Community Verified Swing Trade Signals - newser.com
Will Phathom Pharmaceuticals Inc. stock reach all time highs in 2025Weekly Trend Report & Daily Technical Forecast Reports - newser.com
Phathom Pharmaceuticals stock price target raised to $20 by Guggenheim - Investing.com Australia
Can Phathom Pharmaceuticals Inc. stock sustain market leadershipQuarterly Profit Report & Free Technical Confirmation Trade Alerts - newser.com
How sentiment analysis helps forecast Phathom Pharmaceuticals Inc.Quarterly Portfolio Report & Accurate Buy Signal Alerts - newser.com
Phathom Pharmaceuticals Reports Strong Q3 2025 Growth - TipRanks
Phathom Pharmaceuticals Q3 2025 Earnings Call Transcript - MarketBeat
Phathom Pharmaceuticals Inc (PHAT) Q3 2025 Earnings Call Highlights: Revenue Surge and ... By GuruFocus - Investing.com Canada
Phathom projects $1B GI market opportunity as sales realignment drives 25% revenue growth - MSN
Phathom Pharmaceuticals Inc (PHAT) Q3 2025 Earnings Call Highlights: Revenue Surge and ... - Yahoo Finance
Phathom Pharmaceuticals Inc (PHAT) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Shifts - GuruFocus
Phathom Pharmaceuticals Q3 2025 slides: Revenue up 25% as expenses drop 43% - Investing.com
Phathom Pharmaceuticals Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Earnings call transcript: Phathom Pharmaceuticals Q3 2025 earnings beat boosts stock - Investing.com
Phathom Pharmaceuticals, Inc. (PHAT) reports Q3 loss, tops revenue estimates - FXStreet
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q3 Loss, Tops Revenue Estimates - Yahoo! Finance Singapore
Phathom Pharmaceuticals Inc (PHAT) Q3 2025 Earnings: EPS Misses, Revenue Surpasses Estimates with $49.5 Million - GuruFocus
Earnings Flash (PHAT) Phathom Pharmaceuticals, Inc. Posts Q3 Adjusted Loss $0.15 per Share, vs. FactSet Est of $-0.46 - MarketScreener
Earnings Flash (PHAT) Phathom Pharmaceuticals, Inc. Reports Q3 Revenue $49.50M, vs. FactSet Est of $47.0M - MarketScreener
Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - Caledonian Record
Can Phathom Pharmaceuticals Inc. stock maintain operating marginsQuarterly Growth Report & High Yield Stock Recommendations - newser.com
Is Phathom Pharmaceuticals Inc a good long term investmentHigh Beta Stocks & High Yield Trading Alerts - earlytimes.in
Phathom Pharmaceuticals Inc (PHAT) Q3 2025 Earnings Report Previ - GuruFocus
How strong is Phathom Pharmaceuticals Inc. stock revenue growthJuly 2025 Highlights & Smart Swing Trading Alerts - newser.com
Phathom Pharmaceuticals Inc (PHAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):